Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Lung cancer illustration

Tests with lab animals show synthetic viral RNA particles, encased in natural oils, can safely invoke an immune response to attack solid tumors. . . . → Read More: RNA Cancer Immunotherapy Shown Feasible in Preclinical Test

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Malaria clinic

A vaccine grown in genetically-altered algae, designed as a nasal-spray and edible drug, is shown to protect lab mice against parasite infections causing malaria. . . . → Read More: Algae-Grown Non-Needle Malaria Vaccine in Preclinical Test

Patent Issued for Crispr-Edited Viruses in Microbiome

Crispr-Cas9

A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome

Start-Up Developing Efficient RNA Process, Raises $12M

Vials and bottles

A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M

Company Formed to Boost Clinical Trial Success Odds

Human machine interface

A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds

Start-Up Licenses Gene-Edited Drug Discovery Tech.

African clawed frog

A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech.

Trial Underway Assessing Gut Microbiome-Cancer Links

Gut microbes

A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer. . . . → Read More: Trial Underway Assessing Gut Microbiome-Cancer Links

ALS Treatment Shown Safe, Affects Key Proteins

neurons

Results of a clinical trial show a combination of two approved drugs changes levels of proteins associated with ALS, with patients experiencing few adverse effects. . . . → Read More: ALS Treatment Shown Safe, Affects Key Proteins

Addiction Biotech Using Crowdfunding for Investments

Clock and coins graphic

A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform. . . . → Read More: Addiction Biotech Using Crowdfunding for Investments